The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice
Abstract
Mesial temporal lobe epilepsy is the most common, intractable seizure disorder in adults. It is associated with an asymmetric pattern of hippocampal neuron loss within the endfolium (hilus and CA3) and CA1, with limited pathology in extra-hippocampal regions. We previously developed a model of focally-evoked seizure-induced neuronal death using intra-amygdala kainic acid (KA) microinjection and characterized the acute hippocampal pathology. Here, we sought to characterize the full extent of hippocampal and potential extra-hippocampal damage in this model, and the temporal onset of epileptic seizures. Seizure damage assessed at four stereotaxic levels by FluoroJade B staining was most prominent in ipsilateral hippocampal CA3 where it extended from septal to temporal pole. Minor but significant neuronal injury was present in ipsilateral CA1. Extra-hippocampal neuronal damage was generally limited in extent and restricted to the lateral septal nucleus, injected amygdala and select regions of neocortex ipsilateral to the seizure elicitation side. Continuous surface EEG recorded with implanted telemetry units in freely-moving mice detected spontaneous, epileptic seizures by five days post-KA in all mice. Epileptic seizure number averaged 1-4 per day. Hippocampi from epileptic mice 15 days post-KA displayed unilateral CA3 lesions, astrogliosis and increased neuropeptide Y immunoreactivity suggestive of mossy fiber rearrangement. These studies characterize a mouse model of unilatera…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The model displays typical features of the pathophysiology of TLE including select neuron loss and gliosis within the hippocampus and the emergence of recurrent, spontaneous seizures which are resistant to various anti-seizure medicines (Mouri et al., 2008; West et al., 2022).”
From Brain cell-specific origin of circulating microRNA biomarkers in experimental temporal lobe epilepsy (2023) · cites this paper as Mouri et al., 2008
In the citing paper
“In wildtype animals, seizure-induced damage was observed within the ipsilateral CA3 subfield as expected (Mouri et al., 2008), whereas the bordering seizure-resistant CA2 subfield was spared”
From Brain cell-specific origin of circulating microRNA biomarkers in experimental temporal lobe epilepsy (2023) · cites this paper as Mouri et al., 2008
Citations
Cites
Shibley, H., & Smith, B. N. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00012-8 · Cited by 201
Research works printed but not linked: 60
- Araki, 2002, Characterization of neuronal death induced by focally evoked limbic seizures in the C57BL/6 mouse, J. Neurosci. Res., 69, 614, 10.1002/jnr.10356 · DOI
- Baraban, 1997, Knock-out mice reveal a critical antiepileptic role for neuropeptide Y, J. Neurosci., 17, 8927, 10.1523/JNEUROSCI.17-23-08927.1997 · DOI
- Ben-Ari, 1980, Injections of kainic acid into the amygdaloid complex of the rat: an electrographic, clinical and histological study in relation to the pathology of epilepsy, Neuroscience, 5, 515, 10.1016/0306-4522(80)90049-4 · DOI
- Borges, 2003, Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model, Exp. Neurol., 182, 21, 10.1016/S0014-4886(03)00086-4 · DOI
- Bothwell, 2001, Neuronal hypertrophy in the neocortex of patients with temporal lobe epilepsy, J. Neurosci., 21, 4789, 10.1523/JNEUROSCI.21-13-04789.2001 · DOI
- Brandt, 2003, N-methyl-d-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in kainate model of temporal lobe epilepsy, Neuroscience, 118, 727, 10.1016/S0306-4522(03)00027-7 · DOI
- Chang, 2003, Epilepsy, N. Engl. J. Med., 349, 1257, 10.1056/NEJMra022308 · DOI
- Dawodu, 2005, Quantitative neuropathology of the entorhinal cortex region in patients with hippocampal sclerosis and temporal lobe epilepsy, Epilepsia, 46, 23, 10.1111/j.0013-9580.2005.21804.x · DOI
- DeGiorgio, 1992, Hippocampal pyramidal cell loss in human status epilepticus, Epilepsia, 33, 23, 10.1111/j.1528-1157.1992.tb02278.x · DOI
- Doherty, 2003, Rapid stereological quantitation of temporal neocortex in TLE, Magn. Reson. Imaging, 21, 511, 10.1016/S0730-725X(03)00078-X · DOI
- Du, 1993, Preferential neuronal loss in layer III of the entorhinal cortex in patients with temporal lobe epilepsy, Epilepsy Res., 16, 223, 10.1016/0920-1211(93)90083-J · DOI
- Dudek, 1994, Functional significance of hippocampal plasticity in epileptic brain: electrophysiological changes of the dentate granule cells associated with mossy fiber sprouting, Hippocampus, 4, 259, 10.1002/hipo.450040306 · DOI
- Engel, 2001, Mesial temporal lobe epilepsy: what have we learned?, Neuroscientist, 7, 340, 10.1177/107385840100700410 · DOI
- Fariello, 1989, Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist, Epilepsy Res., 3, 206, 10.1016/0920-1211(89)90025-9 · DOI
- Fujikawa, 2000, Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy, Epilepsia, 41, 981, 10.1111/j.1528-1157.2000.tb00283.x · DOI
- Gouder, 2003, Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy, Epilepsia, 44, 877, 10.1046/j.1528-1157.2003.03603.x · DOI
- Harvey, 2005, Hippocampal granule cell activity and c-Fos expression during spontaneous seizures in awake, chronically epileptic, pilocarpine-treated rats: implications for hippocampal epileptogenesis, J. Comp. Neurol., 488, 442, 10.1002/cne.20594 · DOI
- Hendriksen, 2001, Altered hippocampal gene expression prior to the onset of spontaneous seizures in the rat post-status epilepticus model, Eur. J. Neurosci., 14, 1475, 10.1046/j.0953-816x.2001.01778.x · DOI
- Henshall, 2002, Activation of Bcl-2-associated death protein and counter-response of Akt within cell populations during seizure-induced neuronal death, J. Neurosci., 22, 8458, 10.1523/JNEUROSCI.22-19-08458.2002 · DOI
- Henshall, 2000, Spatio-temporal profile of DNA fragmentation and its relationship to patterns of epileptiform activity following focally evoked limbic seizures, Brain Res., 858, 290, 10.1016/S0006-8993(99)02452-X · DOI
- Hudson, 1993, Amygdaloid sclerosis in temporal lobe epilepsy, Ann. Neurol., 33, 622, 10.1002/ana.410330611 · DOI
- Kasugai, 2007, Differences in two mice strains on kainic acid-induced amygdalar seizures, Biochem. Biophys. Res. Commun., 357, 1078, 10.1016/j.bbrc.2007.04.067 · DOI
- Kienzler, 2006, Excitotoxic hippocampal neuron loss following sustained electrical stimulation of the perforant pathway in the mouse, Brain Res., 1085, 195, 10.1016/j.brainres.2006.02.055 · DOI
- Klitgaard, 2002, Pilocarpine-induced epileptogenesis in the rat: impact of initial duration of status epilepticus on electrophysiological and neuropathological alterations, Epilepsy Res., 51, 93, 10.1016/S0920-1211(02)00099-2 · DOI
- Kubova, 2001, Status epilepticus causes necrotic damage in the mediodorsal nucleus of the thalamus in immature rats, J. Neurosci., 21, 3593, 10.1523/JNEUROSCI.21-10-03593.2001 · DOI
- Li, 2008, Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice, J. Clin. Invest., 118, 571
- Liu, 1999, Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus, Proc. Natl. Acad. Sci. U. S. A., 96, 5286, 10.1073/pnas.96.9.5286 · DOI
- Meldrum, 2002, Implications for neuroprotective treatments, Prog. Brain Res., 135, 487, 10.1016/S0079-6123(02)35046-5 · DOI
- Menini, 1980, Sustained limbic seizures induced by intraamygdaloid kainic acid in the baboon: symptomatology and neuropathological consequences, Ann. Neurol., 8, 501, 10.1002/ana.410080507 · DOI
- Morimoto, 2004, Kindling and status epilepticus models of epilepsy: rewiring the brain, Prog. Neurobiol., 73, 1, 10.1016/j.pneurobio.2004.03.009 · DOI
- Murphy, 2007, Bcl-w protects hippocampus during experimental status epilepticus, Am. J. Pathol., 171, 1258, 10.2353/ajpath.2007.070269 · DOI
- Narkilahti, 2003, Administration of caspase 3 inhibitor during and after status epilepticus in rat: effect on neuronal damage and epileptogenesis, Neuropharmacology, 44, 1068, 10.1016/S0028-3908(03)00115-1 · DOI
- Nissinen, 2000, A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat, Epilepsy Res., 38, 177, 10.1016/S0920-1211(99)00088-1 · DOI
- Nissinen, 2001, Is mossy fiber sprouting present at the time of the first spontaneous seizures in rat experimental temporal lobe epilepsy?, Hippocampus, 11, 299, 10.1002/hipo.1044 · DOI
- Parent, 1997, Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus, J. Neurosci., 17, 3727, 10.1523/JNEUROSCI.17-10-03727.1997 · DOI
- Pitkanen, 1998, Amygdala damage in experimental and human temporal lobe epilepsy, Epilepsy Res., 32, 233, 10.1016/S0920-1211(98)00055-2 · DOI
- Pitkanen, 2005, Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat, Epilepsy Res., 63, 27, 10.1016/j.eplepsyres.2004.10.003 · DOI
- Pitkanen, 2007, Epileptogenesis in experimental models, Epilepsia, 48, 13, 10.1111/j.1528-1167.2007.01063.x · DOI
- Richichi, 2004, Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus, J. Neurosci., 24, 3051, 10.1523/JNEUROSCI.4056-03.2004 · DOI
- Schauwecker, 1997, Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches, Proc. Natl. Acad. Sci. U. S. A., 94, 4103, 10.1073/pnas.94.8.4103 · DOI
- Schwarzer, 1995, Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy, Neuroscience, 69, 831, 10.1016/0306-4522(95)00268-N · DOI
- Shinoda, 2004, Development of a model of seizure-induced hippocampal injury with features of programmed cell death in the BALB/c mouse, J. Neurosci. Res., 76, 121, 10.1002/jnr.20064 · DOI
- Shinoda, 2004, Bim regulation may determine hippocampal vulnerability after injurious seizures and in temporal lobe epilepsy, J. Clin. Invest., 113, 1059, 10.1172/JCI200419971 · DOI
- Sloviter, 1983, "Epileptic" brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies, Brain Res. Bull., 10, 675, 10.1016/0361-9230(83)90037-0 · DOI
- Sloviter, 2005, The neurobiology of temporal lobe epilepsy: too much information, not enough knowledge, C. R. Biol., 328, 143, 10.1016/j.crvi.2004.10.010 · DOI
- Sloviter, 2007, On the relevance of prolonged convulsive status epilepticus in animals to the etiology and neurobiology of human temporal lobe epilepsy, Epilepsia, 48, 6, 10.1111/j.1528-1167.2007.01335.x · DOI
- Tanaka, 1985, Spontaneous secondarily generalized seizures induced by a single microinjection of kainic acid into unilateral amygdala in cats, Electroencephalogr. Clin. Neurophysiol., 61, 422, 10.1016/0013-4694(85)91034-X · DOI
- Tanaka, 1988, Long-term observation of rats after unilateral intra-amygdaloid injection of kainic acid, Brain Res., 463, 163, 10.1016/0006-8993(88)90541-0 · DOI
- Tu, 2005, Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain, J. Neurosci., 25, 1718, 10.1523/JNEUROSCI.4835-04.2005 · DOI
- Tuunanen, 1999, Status epilepticus-induced neuronal damage in the rat amygdaloid complex: distribution, time-course and mechanisms, Neuroscience, 94, 473, 10.1016/S0306-4522(99)00251-1 · DOI
- Vezzani, 1994, Enhanced neuropeptide Y release in the hippocampus is associated with chronic seizure susceptibility in kainic acid treated rats, Brain Res., 660, 138, 10.1016/0006-8993(94)90847-8 · DOI
- Vezzani, 1996, Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures, Epilepsy Res., 26, 267, 10.1016/S0920-1211(96)00059-9 · DOI
- Vezzani, 1999, Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures, J. Neurosci., 19, 5054, 10.1523/JNEUROSCI.19-12-05054.1999 · DOI
- Vezzani, 2002, Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y, Neuroscience, 110, 237, 10.1016/S0306-4522(01)00581-4 · DOI
- Weiergraber, 2005, Electrocorticographic and deep intracerebral EEG recording in mice using a telemetry system, Brain Res. Brain Res. Protoc., 14, 154, 10.1016/j.brainresprot.2004.12.006 · DOI
- Williams, 2002, Reassessment of the effects of cycloheximide on mossy fiber sprouting and epileptogenesis in the pilocarpine model of temporal lobe epilepsy, J. Neurophysiol., 88, 2075, 10.1152/jn.2002.88.4.2075 · DOI
- Williams, 2007, Development of spontaneous seizures after experimental status epilepticus: implications for understanding epileptogenesis, Epilepsia, 48, 157, 10.1111/j.1528-1167.2007.01304.x · DOI
- Woldbye, 1997, Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors, Nat. Med., 3, 761, 10.1038/nm0797-761 · DOI
- Wuarin, 1996, Electrographic seizures and new recurrent excitatory circuits in the dentate gyrus of hippocampal slices from kainate-treated epileptic rats, J. Neurosci., 16, 4438, 10.1523/JNEUROSCI.16-14-04438.1996 · DOI
- Zappone, 2004, Translamellar disinhibition in the rat hippocampal dentate gyrus after seizure-induced degeneration of vulnerable hilar neurons, J. Neurosci., 24, 853, 10.1523/JNEUROSCI.1619-03.2004 · DOI
Cited by
Sorted by citations
Liu, G., Gu, B., He, X.-P., Joshi, R. B., Wackerle, H. D., Rodriguiz, R. M., Wetsel, W. C., & McNamara, J. O. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.027 · Cited by 210
Brain cell-specific origin of circulating microRNA biomarkers in experimental temporal lobe epilepsy
Brindley, E., Heiland, M., Mooney, C., Diviney, M., Mamad, O., Hill, T. D. M., Yan, Y., Venø, M. T., Reschke, C. R., Batool, A., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1230942 · Cited by 21
Self-citationHelgager, J., Liu, G., & McNamara, J. O. (2013) · Journal of Comparative Neurology · doi:10.1002/cne.23225 · Cited by 17
Metadata
- Authors
- Mouri, G., Jimenez-Mateos, E., Engel, T., Dunleavy, M., Hatazaki, S., Paucard, A., Matsushima, S., Taki, W., & Henshall, D. C.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 1213
- Pages
- 140-151
- ISSN
- 0006-8993
- Cited by
- 139
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review